Daniel J. Lippis, CVP, TAVR at Edwards Lifesciences Corp (EW), sold 2,038 shares at $85.38 ($174K) on 2026-03-11, disclosed to the SEC on 2026-03-11.
Open-market sale of $174k EW by CVP, TAVR. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.38 | 1,019 | $87K | 50.0% |
| 2 | $85.38 | 1,019 | $87K | 50.0% |
| Total | $85.38 avg | 2,038 | $174K | 100% |
| Filing → |
| EW | SELL | 2026-08-11 | $57K | — | Filing → |
| EW | SELL | 2026-07-10 | $57K | — | Filing → |
| EW | SELL | 2026-06-30 | $57K | — | Filing → |